To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes ... in a 60-second Super Bowl ad earlier this month, drawing some scrutiny and criticisms. The company bought ...

as the FDA did not consider the drug to be “commercially available” in the U.S. The FDA announced it will allow companies to continue dispensing compounded semaglutide for up to 90 more days.

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity ...

Compounders are on alert after the US Food and Drug Administration (FDA) declared the shortage of semaglutide –the active ingredient in glucagon-like peptide 1 receptor agonist (GLP-1RA ...

The FDA's move is bad news for manufacturers of compounded semaglutide and the telehealth companies that have built up a market selling cheaper alternatives to branded weight loss drugs.